In 2025, Church & Dwight ( NYSE: CHD) expects reported sales growth of approximately of 2.5% to 3.5% and volume-driven ...

Wizz Air stock fell due to Q3 results, revised 2025 outlook, and fleet plan, highlighting high-risk but potentially ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Google's near-term potential looks bright. Click here to read more on how AI can help improve the outlook for GOOGL stock.

Despite risks like geopolitical tensions and high capital expenses, TSMC's long-term vision and market leadership make it a ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The Western US solar fleet is amid rapid growth, with the region being home to four of the top five markets in planned ...

We admit to being miffed by Enovix's continued volatility. So why do we say we expect big things in the future? Click here to ...

We like G Mining Ventures because the mgmt. team is experienced mine builders with access to capital, a rarity among junior ...

Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful ...

Logitech’s underlying growth momentum was great in Q3, driven by good product launches in gaming. Read why I downgraded my ...